Biodesix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.57	18.99	26.25	26.28	43.09	32.71
Cash & Short-Term Investments	25.57	18.99	26.25	26.28	43.09	32.71
Cash Growth	45.27%	-27.66%	-0.15%	-39.00%	31.72%	-47.35%
Accounts Receivable	9.5	9.04	8.6	7.68	5.07	3.66
Other Current Assets	5.84	4.5	4.64	5.72	5.18	7.25
Total Current Assets	40.91	32.52	39.48	39.68	53.33	43.61
Net Property, Plant & Equipment	27.38	27.81	29.6	29.61	8.82	4.18
Other Intangible Assets	3.45	3.88	5.87	7.91	9.8	11.62
Goodwill	15.03	15.03	15.03	15.03	15.03	15.03
Other Long-Term Assets	7.86	8.23	7.26	6.86	5.92	1.66
Total Assets	94.64	87.48	97.24	99.1	92.91	76.1
Accounts Payable	3.65	3.08	2.19	2.93	1.69	1.66
Accrued Expenses	8.23	11.03	10.06	7.71	8.22	7.67
Current Portion of Long-Term Debt	0	0.01	0.02	0.05	0.05	0.02
Current Portion of Leases	1.45	1.36	0.72	0.25	1.54	-
Unearned Revenue	0.22	0.96	0.68	0.32	0.96	1.85
Other Current Liabilities	0.93	0.99	0.64	22.15	10.38	17.76
Total Current Liabilities	14.49	17.44	14.32	33.42	22.84	28.96
Long-Term Debt	46.49	47.45	36.41	35.23	25	9.99
Long-Term Leases	23.67	24.04	24.83	25.16	5.25	-
Other Long-Term Liabilities	0.86	1.02	0.82	0.71	19.2	17.42
Total Long-Term Liabilities	71.02	72.51	62.05	61.1	49.46	27.41
Total Liabilities	85.51	89.94	76.37	94.52	72.3	56.37
Common Stock	0.01	-	-	0.1	0.08	0.03
Additional Paid-in Capital	514.68	495.29	483.37	424.05	387.95	321.67
Retained Earnings	-505.56	-497.76	-462.5	-419.57	-367.42	-301.97
Shareholders' Equity	9.13	-2.47	20.87	4.58	20.61	19.73
Total Liabilities & Equity	94.64	87.48	97.24	99.1	92.91	76.1
Total Debt	71.61	72.85	61.98	60.69	31.85	10.01
Net Cash (Debt)	-46.04	-53.87	-35.73	-34.41	11.24	22.7
Net Cash Growth	-	-	-	-	-50.49%	-33.93%
Net Cash Per Share	-5.66	-7.13	-5.52	-8.38	5.34	16.59
Book Value	9.13	-2.47	20.87	4.58	20.61	19.73
Book Value Per Share	1.12	-0.33	3.23	1.12	9.79	14.42
Tangible Book Value	-9.35	-21.39	-0.04	-18.36	-4.22	-6.92
Tangible Book Value Per Share	-1.15	-2.83	-0.01	-4.47	-2.01	-5.06

SEC Filings: 10-K · 10-Q